Co-reporter:Stephen Neidle
Journal of Medicinal Chemistry 2016 Volume 59(Issue 13) pp:5987-6011
Publication Date(Web):February 3, 2016
DOI:10.1021/acs.jmedchem.5b01835
Quadruplex-forming sequences are widely prevalent in human and other genomes, including bacterial ones. These sequences are over-represented in eukaryotic telomeres, promoters, and 5′ untranslated regions. They can form quadruplex structures, which may be transient in many situations in normal cells since they can be effectively resolved by helicase action. Mutated helicases in cancer cells are unable to unwind quadruplexes, which are impediments to transcription, translation, or replication, depending on their location within a particular gene. Small molecules that can stabilize quadruplex structures augment these effects and produce cell and proliferation growth inhibition. This article surveys the chemical biology of quadruplexes. It critically examines the major classes of quadruplex-binding small molecules that have been developed to date and the various approaches to discovering selective agents. The challenges of requiring (and achieving) small-molecule targeted selectivity for a particular quadruplex are discussed in relation to the potential of these small molecules as clinically useful therapeutic agents.
Co-reporter:John Mann, Peter W. Taylor, Colin R. Dorgan, Peter D. Johnson, Francis X. Wilson, Richard Vickers, Aaron G Dale and Stephen Neidle
MedChemComm 2015 vol. 6(Issue 8) pp:1420-1426
Publication Date(Web):01 Jul 2015
DOI:10.1039/C5MD00238A
Academic drug discovery is playing an increasingly important role in the identification of new therapies for a wide range of diseases. There is no one model that guarantees success. We describe here a drug discovery story where chance, the ability to capitalise on chance, and the assembling of a range of expertise, have all played important roles in the discovery and subsequent development of an antibiotic chemotype based on the bis-benzimidazole scaffold, with potency against a number of current therapeutically challenging diseases. One compound in this class, SMT19969, has recently entered Phase 2 human clinical trials for the treatment of Clostridium difficile infections.
Co-reporter:Stephen Neidle
The Chemical Record 2015 Volume 15( Issue 4) pp:691-710
Publication Date(Web):
DOI:10.1002/tcr.201500011
Abstract
The story behind some of the early studies in the laboratory of Stephen Neidle on quadruplex-binding small molecules and the structural studies on quadruplexes and their complexes is presented and discussed in the context of his earlier work on drug–DNA interactions. More recent studies and future directions in the rational design of small molecules targeting telomeric and gene promoter quadruplexes are also described.
Co-reporter:Stephan A. Ohnmacht, Ehsan Varavipour, Rupesh Nanjunda, Ingrida Pazitna, Gloria Di Vita, Mekala Gunaratnam, Arvind Kumar, Mohamed A. Ismail, David W. Boykin, W. David Wilson and Stephen Neidle
Chemical Communications 2014 vol. 50(Issue 8) pp:960-963
Publication Date(Web):02 Dec 2013
DOI:10.1039/C3CC48616H
We report here on the discovery and preliminary evaluation of a novel non-macrocyclic low molecular weight quadruplex-stabilizing chemotype. The lead compounds, based on a furan core, show high G-quadruplex stabilisation and selectivity as well as potent in vitro anti-proliferative activity.
Co-reporter:Stephan A. Ohnmacht, Stephen Neidle
Bioorganic & Medicinal Chemistry Letters 2014 Volume 24(Issue 12) pp:2602-2612
Publication Date(Web):15 June 2014
DOI:10.1016/j.bmcl.2014.04.029
Repeated guanine tracts in human and other genomes can form higher-order four stranded structures, termed quadruplexes. In the human genome they have particular prevalence in telomeric and promoter regions and also in 5′-UTRs and introns. These structures, if unresolved and stabilised by small molecules, can form impediments to transcription and translation, and thus can be considered as a form of gene targeting. This Digest surveys the major types of quadruplex-binding small molecules that have been designed and studied to date and directs attention to directions where future development of more drug-like compounds is likely to be most productive.Figure optionsDownload full-size imageDownload as PowerPoint slide
Co-reporter:Dengguo Wei ; Alan K. Todd ; Mire Zloh ; Mekala Gunaratnam ; Gary N. Parkinson
Journal of the American Chemical Society 2013 Volume 135(Issue 51) pp:19319-19329
Publication Date(Web):December 2, 2013
DOI:10.1021/ja4101358
The sequence d(GGGCGGGGAGGGGGAAGGGA) occurs in the promoter region of the B-raf gene. An X-ray crystallographic study has found that this forms an unprecedented dimeric quadruplex arrangement, with a core of seven consecutive G-quartets and an uninterrupted run of six potassium ions in the central channel of the quadruplex. Analogy with previously reported promoter quadruplexes had initially suggested that in common with these a monomeric quadruplex was to be expected. The structure has a distorted G·C·G·C base quartet at one end and four flipped-out adenosine nucleosides at the other. The only loops in the structure are formed by the cytosine and by the three adenosines within the sequence, with all of the guanosines participating in G-quartet formation. Solution UV and circular dichroism data are in accord with a stable quadruple arrangement being formed. 1D NMR data, together with gel electrophoresis measurements, are consistent with a dimer being the dominant species in potassium solution. A single-chain intramolecular quadruplex has been straightforwardly constructed using molecular modeling, by means of a six-nucleotide sequence joining 3′ and 5′ ends of each strand in the dimer. A human genomic database search has revealed a number of sequences containing eight or more consecutive short G-tracts, suggesting that such intramolecular quadruplexes could be formed within the human genome.
Co-reporter:Marialuisa Micco ; Gavin W. Collie ; Aaron G. Dale ; Stephan A. Ohnmacht ; Ingrida Pazitna ; Mekala Gunaratnam ; Anthony P. Reszka
Journal of Medicinal Chemistry 2013 Volume 56(Issue 7) pp:2959-2974
Publication Date(Web):March 21, 2013
DOI:10.1021/jm301899y
Tetra-substituted naphthalene diimide (ND) derivatives with positively charged termini are potent stabilizers of human telomeric and gene promoter DNA quadruplexes and inhibit the growth of human cancer cells in vitro and in vivo. The present study reports the enhancement of the pharmacological properties of earlier ND compounds using structure-based design. Crystal structures of three complexes with human telomeric intramolecular quadruplexes demonstrate that two of the four strongly basic N-methyl-piperazine groups can be replaced by less basic morpholine groups with no loss of intermolecular interactions in the grooves of the quadruplex. The new compounds retain high affinity to human telomeric quadruplex DNA but are 10-fold more potent against the MIA PaCa-2 pancreatic cancer cell line, with IC50 values of ∼10 nM. The lead compound induces cellular senescence but does not inhibit telomerase activity at the nanomolar dosage levels required for inhibition of cellular proliferation. Gene array qPCR analysis of MIA PaCa-2 cells treated with the lead compound revealed significant dose-dependent modulation of a distinct subset of genes, including strong induction of DNA damage responsive genes CDKN1A, DDIT3, GADD45A/G, and PPM1D, and repression of genes involved in telomere maintenance, including hPOT1 and PARP1.
Co-reporter:Sheila Mpima, Stephan A. Ohnmacht, Maria Barletta, Jarmila Husby, Luke C. Pett, Mekala Gunaratnam, Stephen T. Hilton, Stephen Neidle
Bioorganic & Medicinal Chemistry 2013 Volume 21(Issue 20) pp:6162-6170
Publication Date(Web):15 October 2013
DOI:10.1016/j.bmc.2013.05.027
The synthesis together with biophysical and biological evaluation of a series of tetra-substituted naphthalene diimide (ND) compounds, are presented. These compounds are positional isomers of a recently-described series of quadruplex-binding ND derivatives, in which the two N-methyl-piperidine-alkyl side-chains have now been interchanged with the positions of side-chains bearing a range of end-groups. Molecular dynamics simulations of a pair of positional isomers are in accord with the quadruplex stabilization and biological data for these compounds. Analysis of structure–activity data indicates that for compounds where the side-chains are not of equivalent length then the positional isomers described here tend to have improved cell proliferation potency and in some instances, superior quadruplex stabilization ability.
Co-reporter:Stephan A. Ohnmacht, Cristina Ciancimino, Giulia Vignaroli, Mekala Gunaratnam, Stephen Neidle
Bioorganic & Medicinal Chemistry Letters 2013 23(19) pp: 5351-5355
Publication Date(Web):
DOI:10.1016/j.bmcl.2013.07.057
Co-reporter:Jarmila Husby;Alan K. Todd;James A. Platts
Biopolymers 2013 Volume 99( Issue 12) pp:989-1005
Publication Date(Web):
DOI:10.1002/bip.22340
ABSTRACT
G-quadruplexes are higher-order four-stranded structures formed from repetitive guanine-containing tracts in nucleic acids. They comprise a core of stacked guanine-quartets linked by loops of length and sequence that vary with the context in which the quadruplex sequence occurs. Such sequences can be found in a number of genomic environments; at the telomeric ends of eukaryotic chromosomes, in promoter regions, in untranslated sequences and in open reading frames. Quadruplex formation can inhibit telomere maintenance, transcription and translation, especially when enhanced by quadruplex-binding small molecules, and quadruplex targeting is currently of considerable interest. The available experimental structural data shows that quadruplexes can have high conformational flexibility, especially in loop regions, which has hampered attempts to use high-throughput docking to find quadruplex-binding small-molecules with new scaffolds or to optimize existing ones with structure-based design methods. An approach to overcome the challenge of quadruplex conformational flexibility is presented here, which uses a combined multiple molecular dynamics and sampling approach. Two test small molecules have been used, RHPS4 and pyridostatin, which themselves have contrasting degrees of conformational flexibility. © 2013 Wiley Periodicals, Inc. Biopolymers 99: 989–1005, 2013.
Co-reporter:DengGuo Wei ; W David Wilson
Journal of the American Chemical Society 2012 Volume 135(Issue 4) pp:1369-1377
Publication Date(Web):December 31, 2012
DOI:10.1021/ja308952y
High-resolution crystal structures of the DNA duplex sequence d(CGCGAATTCGCG)2 complexed with three minor-groove ligands are reported. A highly conserved cluster of 11 linked water molecules has been found in the native and all 3 ligand-bound structures, positioned at the boundary of the A/T and G/C regions where the minor groove widens. This cluster appears to play a key structural role in stabilizing noncovalently binding small molecules in the AT region of the B-DNA minor groove. The cluster extends from the backbone phosphate groups along the mouth of the groove and links to DNA and ligands by a network of hydrogen bonds that help to maintain the ligands in position. This arrangement of water molecules is distinct from, but linked by, hydrogen bonding to the well-established spine of hydration, which is displaced by bound ligands. Features of the water cluster and observed differences in binding modes help to explain the measured binding affinities and thermodynamic characteristics of these ligands on binding to AT sites in DNA.
Co-reporter:Jarmila Husby, Alan K. Todd, Shozeb M. Haider, Giovanna Zinzalla, David E. Thurston, and Stephen Neidle
Journal of Chemical Information and Modeling 2012 Volume 52(Issue 5) pp:1179-1192
Publication Date(Web):April 16, 2012
DOI:10.1021/ci200625q
Signal Transducers and Activators of Transcription (STAT) proteins are a group of latent cytoplasmic transcription factors involved in cytokine signaling. STAT3 is a member of the STAT family and is expressed at elevated levels in a large number of diverse human cancers and is now a validated target for anticancer drug discovery.. Understanding the dynamics of the STAT3 dimer interface, accounting for both protein–DNA and protein–protein interactions, with respect to the dynamics of the latent unphosphorylated STAT3 monomer, is important for designing potential small-molecule inhibitors of the activated dimer. Molecular dynamics (MD) simulations have been used to study the activated STAT3 homodimer:DNA complex and the latent unphosphorylated STAT3 monomer in an explicit water environment. Analysis of the data obtained from MD simulations over a 50 ns time frame has suggested how the transcription factor interacts with DNA, the nature of the conformational changes, and ways in which function may be affected. Examination of the dimer interface, focusing on the protein–DNA interactions, including involvement of water molecules, has revealed the key residues contributing to the recognition events involved in STAT3 protein–DNA interactions. This has shown that the majority of mutations in the DNA-binding domain are found at the protein–DNA interface. These mutations have been mapped in detail and related to specific protein–DNA contacts. Their structural stability is described, together with an analysis of the model as a starting-point for the discovery of novel small-molecule STAT3 inhibitors.
Co-reporter:Aaron G. Dale, Jason Hinds, John Mann, Peter W. Taylor, and Stephen Neidle
Biochemistry 2012 Volume 51(Issue 29) pp:
Publication Date(Web):July 2, 2012
DOI:10.1021/bi300645n
Various bis-benzimidazole derivatives have been reported to possess activity against Gram-positive pathogens. No mechanism of action has been elucidated to fully account for the antibacterial activity of this class of compounds. A group of symmetric bis-benzimidazoles (BBZ) designed as anticancer agents have previously been shown to possess moderate antiproliferative activity. We sought to assess the antibacterial activity and mechanism of action of BBZ compounds against Staphylococcus aureus. Antibacterial activities were assessed by determination of minimal inhibitory concentrations (MICs), time-kill curves, and scanning electron microscopy. Transcriptional responses to BBZ treatment were determined using whole genome microarrays. Activities against bacterial type II topoisomerases were investigated using in vitro supercoiling, decatenation, DNA binding, and DNA cleavage inhibition assays. MICs for EMRSA-16 were between 0.03 and 0.5 μg/mL. The compounds showed concentration-dependent bactericidal activity and induced cell swelling and lysis. Transcriptional responses to BBZ were consistent with topoisomerase inhibition and DNA damage. A subset of BBZ compounds inhibited S. aureus DNA gyrase supercoiling activity with IC50 values in the range of 5–10 μM. This inhibition was subsequently shown to operate through both inhibition of binding of DNA gyrase to DNA and accumulation of single-stranded DNA breaks. We conclude that BBZ compounds are potent anti-staphylococcal agents and operate at least in part through DNA gyrase inhibition, leading to the accumulation of single-stranded DNA breaks, and by preventing the binding of gyrase to DNA.
Co-reporter:Stephan A. Ohnmacht, Marialuisa Micco, Vanessa Petrucci, Alan K. Todd, Anthony P. Reszka, Mekala Gunaratnam, Marta A. Carvalho, Mire Zloh, Stephen Neidle
Bioorganic & Medicinal Chemistry Letters 2012 Volume 22(Issue 18) pp:5930-5935
Publication Date(Web):15 September 2012
DOI:10.1016/j.bmcl.2012.07.065
The HSP90 protein is an important target in cancer. We report here that stable quadruplex DNAs can be formed from a promoter sequence in the HSP90 gene, on the basis of melting, circular and NMR studies, and show that these can be selectively targeted by non-macrocyclic quadruplex-stabilizing phenyl bis-oxazole derivatives. These do not bind significantly to duplex DNA and show low stabilization of the human telomeric quadruplex. These results suggest an approach to targeting HSP90 at the DNA level.
Co-reporter:Stephen Neidle
Methods (May 2012) Volume 57(Issue 1) pp:1-2
Publication Date(Web):1 May 2012
DOI:10.1016/j.ymeth.2012.05.014
Co-reporter:Stephan A. Ohnmacht, Ehsan Varavipour, Rupesh Nanjunda, Ingrida Pazitna, Gloria Di Vita, Mekala Gunaratnam, Arvind Kumar, Mohamed A. Ismail, David W. Boykin, W. David Wilson and Stephen Neidle
Chemical Communications 2014 - vol. 50(Issue 8) pp:NaN963-963
Publication Date(Web):2013/12/02
DOI:10.1039/C3CC48616H
We report here on the discovery and preliminary evaluation of a novel non-macrocyclic low molecular weight quadruplex-stabilizing chemotype. The lead compounds, based on a furan core, show high G-quadruplex stabilisation and selectivity as well as potent in vitro anti-proliferative activity.